VALBIOTIS (EPA:ALVAL) | Finanzwire

Basculer en Français

9773	Companies
195568	Keywords
126553	Articles
103965	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 06/26/2025 at 17:40, 7 months 3 days ago

VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue entirely dedicated to supporting the commercial expansion of its offering of dietary supplements
Valbiotis successfully completes €6.9 million rights issue to enhance commercial expansion of dietary supplements. Sébastien Peltier shows renewed commitment

Rights Issue Valbiotis Dietary Supplements Commercial Expansion Sébastien Peltier
PRESS RELEASE

published on 06/26/2025 at 17:40, 7 months 3 days ago

VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue entirely dedicated to supporting the commercial expansion of its offering of dietary supplements
Valbiotis announces success of €6.9 million rights issue to support commercial expansion of dietary supplements. Strong interest from shareholders

Shareholders Rights Issue Valbiotis Dietary Supplements Commercial Expansion
BRIEF

published on 06/06/2025 at 08:05, 7 months 23 days ago

Valbiotis Announces Capital Increase of €6.9 Million

Capital Increase Valbiotis Dietary Supplements Subscription Rights Commercial Strategy
PRESS RELEASE

published on 06/06/2025 at 08:00, 7 months 23 days ago

VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintained preferential subscription rights for a gross amount of nearly €6.9 million, secured by subscription commitments of 75
Valbiotis announces a capital increase of nearly €6.9 million with preferential subscription rights, aiming to finance its commercial strategy and sales growth of health supplements. Subscription period from 12 to 24 June 2025

Capital Increase Valbiotis Subscription Rights Commercial Strategy Health Supplements
BRIEF

published on 06/02/2025 at 22:53, 7 months 27 days ago

Valbiotis: Information on Share Capital and Voting Rights

Share Capital Voting Rights Euronext Growth Valbiotis AMF Regulation
BRIEF

published on 06/02/2025 at 22:53, 7 months 27 days ago

VALBIOTIS: Information on Share Capital and Voting Rights

Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossing
BRIEF

published on 05/22/2025 at 17:45, 8 months 7 days ago

Valbiotis to Launch ValbiotisPRO® Cardio-circulation on 2 June

Valbiotis Dietary Supplements Pharmacy Network Cardio-circulation Tensodrive
PRESS RELEASE

published on 05/22/2025 at 17:40, 8 months 7 days ago

VALBIOTIS SA: Valbiotis to launch ValbiotisPRO® Cardio-circulation on 2 June
Valbiotis announces the launch of ValbiotisPRO® Cardio-circulation on 2 June, expanding its range of scientifically tested dietary supplements to support cardiometabolic balance. Multichannel marketing strategy accelerates with listings in supplemental insurance companies

Dietary Supplements Scientific Multichannel Marketing ValbiotisPRO® Cardio-circulation Cardiometabolic Balance
BRIEF

published on 05/14/2025 at 17:13, 8 months 15 days ago

VALBIOTIS SA: Data on voting rights and shares as of April 30, 2025

Share Capital Voting Rights Euronext Growth Valbiotis Crossing Thresholds
BRIEF

published on 05/06/2025 at 17:45, 8 months 23 days ago

Valbiotis: Strong Market Entry with Strategic Expansion and New Launches

Sales Growth Valbiotis Product Launches Strategic Goals Pharmacy Network

Accesswire

Published on 01/30/2026 at 02:15, 1 hour 4 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 3 hours 19 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 4 hours 19 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 8 hours 34 minutes ago

Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 9 hours 19 minutes ago

PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 00:07, 3 hours 11 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 6 hours 16 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 6 hours 18 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/29/2026 at 20:59, 6 hours 19 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 01/29/2026 at 20:57, 6 hours 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 01/29/2026 at 18:00, 9 hours 19 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 9 hours 34 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 9 hours 34 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 9 hours 39 minutes ago

ALTEN: Annual revenue 2025
Published on 01/29/2026 at 10:07, 17 hours 11 minutes ago

Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech

View all LES ECHOS COMFI WIRE